Jonathan Hawkins - Mar 10, 2022 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
Chief Revenue Officer
Signature
/s/ Todd Holvick, Attorney-in-Fact
Stock symbol
AUGX
Transactions as of
Mar 10, 2022
Transactions value $
$0
Form type
4
Date filed
3/11/2022, 07:09 PM
Next filing
Feb 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Employee Stock Option (right to buy) Award $0 +100K $0.00 100K Mar 10, 2022 Common Stock 100K $2.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. The option will vest monthly in equal increments for four years starting on March 10, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date, and will be fully vested on March 10, 2026.